| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group
|
Duerinck, Johnny
|
|
|
216 |
C |
p.
|
artikel
|
| 2 |
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies
|
Ribrag, Vincent
|
|
|
216 |
C |
p.
|
artikel
|
| 3 |
Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion
|
Buriolla, Silvia
|
|
|
216 |
C |
p.
|
artikel
|
| 4 |
A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response to neoadjuvant chemoradiotherapy: Transanal endoscopic microsurgery ——A multicenter prospective case-control clinical trial by MONT-R
|
Qiu, Xiaoyuan
|
|
|
216 |
C |
p.
|
artikel
|
| 5 |
An update on access to novel treatment for metastatic melanoma in Europe — A 2024 survey of the European melanoma registry and the European association of dermato-oncology
|
Kandolf, L.
|
|
|
216 |
C |
p.
|
artikel
|
| 6 |
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial
|
Oaknin, Ana
|
|
|
216 |
C |
p.
|
artikel
|
| 7 |
Corrigendum to “Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry” [Eur. J. Cancer 212, 2024, 115056]
|
Özkan, A.
|
|
|
216 |
C |
p.
|
artikel
|
| 8 |
Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
|
Yu, Kin Lam
|
|
|
216 |
C |
p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
216 |
C |
p.
|
artikel
|
| 10 |
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers
|
Kitapli, Sait
|
|
|
216 |
C |
p.
|
artikel
|
| 11 |
Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients
|
Lena, Jeanne
|
|
|
216 |
C |
p.
|
artikel
|
| 12 |
Extracorporeal photopheresis effective in immune-related capillary leak/polyserositis in splenectomized patient
|
Ertl, C.
|
|
|
216 |
C |
p.
|
artikel
|
| 13 |
Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate
|
Walstra, Anna N.H.
|
|
|
216 |
C |
p.
|
artikel
|
| 14 |
Glucagon-like Peptide‐1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors
|
Chiang, Cho-Han
|
|
|
216 |
C |
p.
|
artikel
|
| 15 |
Gut microbiome and immune checkpoint inhibitor toxicity
|
Verheijden, Rik J.
|
|
|
216 |
C |
p.
|
artikel
|
| 16 |
Letter Re: Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers
|
Wang, Ziyi
|
|
|
216 |
C |
p.
|
artikel
|
| 17 |
Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA
|
Nielsen, Signe Bergliot
|
|
|
216 |
C |
p.
|
artikel
|
| 18 |
Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T
|
Tomsitz, Dirk
|
|
|
216 |
C |
p.
|
artikel
|
| 19 |
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides
|
Marmé, Frederik
|
|
|
216 |
C |
p.
|
artikel
|
| 20 |
Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program
|
Di Carlo, D.
|
|
|
216 |
C |
p.
|
artikel
|
| 21 |
Response to Letter Entitled “Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers”
|
Feng, Yingfang
|
|
|
216 |
C |
p.
|
artikel
|
| 22 |
Response to letter re: “Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers”
|
Feng, Yingfang
|
|
|
216 |
C |
p.
|
artikel
|
| 23 |
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy
|
Poumeaud, F.
|
|
|
216 |
C |
p.
|
artikel
|
| 24 |
The Winner and still champion: Nodule volume doubling times
|
Yankelevitz, David F.
|
|
|
216 |
C |
p.
|
artikel
|
Tijdschrift beschrijving